3
Announcements
Trials
Browse
Landscape
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
1
Other solid neoplasm
1
Head & Neck
1
Conditions
Mesothelioma
3
Solid Tumor, Adult
2
Solid Tumor
2
Retinoblastoma
2
Thyroid Neoplasms
1
Thymus Neoplasms
1
Small Cell Lung Carcinoma
1
Pneumothorax
1
Pleural Neoplasms
1
Pediatric Solid Tumor, Unspecified, Protocol Specific
1
Parathyroid Neoplasms
1
Neoplasms
1
Mesothelioma, Malignant
1
Lung Neoplasms
1
Hemostatic Disorders
1
Head and Neck Neoplasms
1
Carcinoma, Squamous Cell
1
Carcinoma, Non-Small-Cell Lung
1
Anatomic Stage III Breast Cancer AJCC v8
1
Advanced Solid Tumor
1
Adenocarcinoma
1
Interventions
Cisplatin
57
Pemetrexed
46
pembrolizumab
18
Nivolumab
15
Carboplatin
15
Gemcitabine
14
Cyclophosphamide
13
Radiotherapy
10
Drug Therapy
9
atezolizumab
8
Platinum
7
Ipilimumab
7
Doxorubicin
7
durvalumab
6
1,2-diaminocyclohexaneplatinum II citrate
6
tremelimumab
5
sodium thiosulfate
5
Vinorelbine
5
Radiotherapy, Intensity-Modulated
5
Interleukin-2
5
Chemotherapy, Adjuvant
5
Cerebral Decortication
5
sargramostim
4
fludarabine
4
defactinib
4
aldesleukin
4
tumor necrosis factor-alpha, CNGRC fusion protein, human
3
cediranib
3
Photochemotherapy
3
Neoadjuvant Therapy
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Mesothelioma, Malignant
×
Blood Specimen Collection
×
Other solid neoplasm
×
Clear all
NCT07550049
2026-04-24
COMETH
University of Kansas Medical Center
Not yet recruiting
110 enrolled